Clinical Trial Update: An Open-labelled Clinical Trial of Live Attenuated Varicella Vaccines to Evaluate the Immunity Persistence After Primary Immunization and Safety and Immunogenicity After the Booster Immunization [Phase 3]

View source ↗

Summary

Phase 3 open-label trial assessing immunity persistence after primary varicella vaccination and safety/immunogenicity after booster vaccination.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella

Drugs mentioned

• Unspecified varicella vaccine (live attenuated)

Snippet

Sponsor: Sinovac (Dalian) Vaccine Technology Co., Ltd. | Conditions: Varicella | Phase 3 | Status: COMPLETED